TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
70
|
184
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
40
|
144
|
-2 |
| EBITDA |
38
|
143
|
-2 |
| Total assets |
308
|
289
|
157 |
| Current assets |
72
|
100
|
2 |
| Current liabilities |
5
|
11
|
1 |
| Equity capital |
290
|
268
|
153 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.2%
|
92.7%
|
97.5% |
| Turnover per employee |
70
|
184 | |
| Profit as a percentage of turnover |
57.1%
|
78.3% | |
| Return on assets (ROA) |
13.0%
|
49.8%
|
-1.3% |
| Current ratio |
1440.0%
|
909.1%
|
200% |
| Return on equity (ROE) |
13.8%
|
53.7%
|
-1.3% |
| Change turnover |
-108
|
184
|
0 |
| Change turnover % | -61% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.